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MalignancyAbstract Background: There is no consensus regarding optimal management of biliary metal
stent occlusion.
Aim: To evaluate the efﬁcacy of different percutaneous methods for managing biliary metal stent
occlusion.
Patients and methods: Thirty-eight patients were included in the study. Metal biliary stent occlu-
sions were managed by insertion of another metal stent in 18 patients (group 1), insertion of an
internal–external catheter in 15 patients (group 2), and mechanical cleaning in 5 patients (group 3).
Results: The clinical success was achieved with bilirubin decreased from 16.0 (7.5–34.3) to 4.1
(1.2–5.7) mg/dl (p< 0.05) with no signiﬁcant differences among all groups. No major complica-
tions occurred. The median duration of metal stent patency was 75 days (43–107) after insertion
of another metal stent (group 1), 90 days (71–109) after insertion of plastic internal–external
catheters (group 2), and 54 days (30–68) after mechanical cleaning (group 3) with no signiﬁcant dif-
ference. Incremental cost effective analysis showed that plastic internal–external catheters insertion
is the most cost effective option.
Conclusion: Although the three methods are equally effective in managing an occluded metal stent,
the most cost effective method appears to be plastic internal–external catheters insertion.
 2015 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
Self expandable metallic stents such as Wallstent (Schneider
Stent Inc., Minneapolis, Minnesota, USA) have been usedfor the management of biliary strictures to provide permanent
bile drainage. The commercially available metal stent is a tubu-
lar stainless steel uncovered super-alloy mesh delivered in a
constrained form on an 8 or 7.5 French gauge catheter system
which, when deployed, expands to a ﬁnal diameter of 24 or 30
French gauge (8 or 10 mm) and shortens to a length of 42, 68,
or 80 mm. The stent is deployed using the Unistep system
which allows easy retraction of the covering membrane after
internal wetting of its inner hydrophilic coating.ed.
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the palliation of malignant biliary obstruction is that they have
a longer patency and despite the initial cost, have been shown
to be cost effective (1). Metal stents still occlude after a median
interval of nine months 12 unlike plastic stents, and metal
stents cannot be extracted or pushed in the duodenum.
Several methods have been used in the management of the
occlusion such as insertion of another metal stent, or internal–
external catheter, or mechanical cleaning. There are currently
no data comparing the efﬁcacy of the different management
options and follow up of the metal stent occlusion. Such data
would be useful in deciding on optimal management. The aim
of our study was to compare the efﬁcacy of different ways used
to manage the occluded metal biliary stents.
2. Patients and methods
This retrospective study was undertaken in the National Liver
Institute from the period of 2008 till 2013 on patients who were
treated for biliary metal stent occlusion. The patients included
28 men and 10 women, with a median age of 66 years (range,
42–71 years). All primary metal stents were correctly deployed
across a biliary stricture to allow bile drainage. Patients
characteristics are seen in Table 1.
2.1. Procedures
All procedures were performed after informed written con-
sents. The technique for insertion of the stents was carried
out in the standard fashion (2) after doing the multi-slice CT
to deﬁne the cause and level of obstruction. After selection
of the proper entry site, the Chiba needle was inserted through
the left/right transhepatic route to reach the dilated duct.
Contrast injection was done to do cholangiography to evaluate
the pathological cause. Tumor ingrowth was assumed when
cholangiography showed a tight stricture within the stent,
the appearance of which was similar to the original malignant
stricture, and passage of a diagnostic catheter was difﬁcult.
Tumor overgrowth was assumed when cholangiography
showed a new stricture proximal or distal to the stent.
Debris or sludge occlusion was diagnosed when cholangiogra-
phy showed ﬁlling defects within the lumen of the stent andTable 1 Patient characteristics on entry to study (n= 84).
Parameter Group 1 (n= 18)
Liver and renal functions Mean + SD
– Bil T 28 ± 9
– ALT 189 ± 112
– AST 233 ± 18
– ALK 1079 ± 125
– Creatinine 1 ± 0.2
Co-morbid diseases
– HCV 4
– Diabetes 0
– Cardiac 1
Causes of obstruction
– Distal 14
– Hilar 5further instrumentation showed passage of debris through
the distal portion of the stent conﬁrmed percutaneously.
Stent migration was diagnosed when the site of the stent is
compared to that of the previous position. When the metal
stents became occluded, they were managed either by insertion
of another metal stent within/beside the ﬁrst one (group 1)
(Figs. 1–4), an internal–external catheter within/beside the ﬁrst
metal stent (group 2) (Figs. 5 and 6), or mechanical cleaning of
the metal stent (group 3) (Fig. 7). Mechanical cleaning was
deﬁned as passage of an instrument (balloon or catheter) to
allow recanalization of the metal stent to allow biliary drai-
nage. Plastic internal–external catheters were either the curved
10 French pigtail catheters (in 86%) (HS, Italy and Boston
Scientiﬁc Medical Inc., USA) or the straight Maliicot catheters
(in 14%) (Wilson-Cook Medical Inc., Winston-Salem, North
Carolina, USA).
2.2. Study of endpoints and deﬁnitions
Follow up data were obtained from the patient’s medical
record and/or by contacting their primary care physician.
Management of the metal stent occlusion was considered suc-
cessful if there was clinical improvement with a signiﬁcant fall
in bilirubin following intervention. Second biliary patency rep-
resented the interval between the time of treatment of the stent
occlusion and the time of its re-occlusion or the death of the
patient with jaundice and fever. Survival represented the inter-
val between the time of treatment of the metal stent occlusion
and the patient’s death. Death without jaundice or sepsis was
assumed to be due to causes other than stent occlusion. All
complications of the procedure were divided into major and
minor categories according to the reporting standards of the
Society of Interventional Radiology. Major complications
included postprocedural sepsis or cholangitis, hemorrhage
requiring blood transfusion, abscess, peritonitis, cholecystitis,
pancreatitis, pneumonia or pleural infection. All other compli-
cations were considered minor, including self-limited hemor-
rhage, biliovenous ﬁstula, subcapsular biloma, catheter
dislodgement, and stent migration, which were all either trea-
ted promptly with simple maneuvers by the interventionist or
did not require further intervention, blood transfusion, or an
extended stay in the hospital. The cost for all treatment strate-
gies differed only with respect to the speciﬁc equipment price.Group 2 (n= 15) Group 3 (n= 5)
Mean + SD Mean + SD
28 ± 9 26 ± 8
189 ± 112 211 ± 145
233 ± 18 202 ± 17
1079 ± 125 1214 ± 133
1 ± 0.2 1.1 ± 0.12
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Fig. 1 Male patient, 70 years old with obstructed metal stents for malignant pancreatic head mass. US (A and B) revealed marked
intrahepatic radicles and dilated CBD, stent inside it. The triphasic CT (C and D) showed dilated IHBR, dilated CBD with stent inside it.
The pancreatic head mass encroaches upon the distal end of the stent (tumor over-growth). Picture (E) shows the original stent before
obstruction. Re-cholangiographies (F–J) show the steps of re-canalizing the stent. Stent-N-stent technique was used to deploy 10 · 94 mm
uncovered Wall stent inside the old one and dilated with 8 · 40 mm balloon catheter. Bilirubin decreased to T: 0.8/D: 0.6, patient was back
on chemotherapy, died 7 months after stent insertion.
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Fig. 2 Female patient, 53 years old, diagnosed with distal malignant biliary obstruction due to pancreatic head neoplasm. Metal stent
was inserted and occluded. ERCP stent was re-used but occluded as well. Her CT (A–E) shows dilated biliary radicles with plastic and
metal stents in the tree. No overgrowth of the tumor. Cholangiography and stenting and re-stenting (F–K). An extra-stent was inserted
inside the metal one and adjacent to the ERCP stent. The 10 · 94 mm uncovered wall stent was inserted through right approach and was
dilated with 8· 4 0 mm balloon (J), and good drainage is obtained (K).
652 M. Alwarraky et al.The cost of the stent was ﬁvefolds for that of the balloon
used for mechanical cleaning and 14-folds for that of the
plastic internal–external catheter. The basic equipment
for all procedures was similar (needle, catheters, wires).
Effectiveness was expressed as mean number of procedures
necessary for each treatment strategy until death or the end
of evaluation. Bilirubin concentrations before and after treat-
ment were analyzed using the Kruskal–Wallis test. A p value
of less than 0.05 was considered signiﬁcant. Correlation
between the period of patency of the ﬁrst metal stent and the
period of patency of the second procedure was analyzed using
regression analysis.3. Results
A total of 38 patients with 42 metal stent occlusions were
included. The distributions of primary metal stents inserted
which became occluded were: one metal stent in 34 patients
and 2 metal stents in 4 patients. Indications for the metal stents
were: distal obstruction (from pancreatic carcinoma, peri-
ampullary carcinoma and metastatic carcinomas) in 30/38
patients and hilar obstructions (from cholangiocarcinoma, lym-
phoma and gall bladder carcinoma and HCC) in 8/38 patients.
Median duration of ﬁrst metal stent patency was 102 days
(range 12–280). Metal stent occlusions presented as:
F G
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Fig. 2 (continued)
Evaluation of different percutaneous modalities 653cholangitis (fever, abdominal pains and jaundice) in 25/38
(65.7%), painless jaundice in 11/38 (28.9), pruritus in one,
and were unspeciﬁed in one. The cause of metal stent occlusion
was: tumor ingrowth only in 5/38 patients (13%), tumor
ingrowth and overgrowth in 14/38 patients (37%), tumor over-
growth only in 9/38 patients (24%), debris in 6/38 patients
(16%), stent migration in 2/38 (5%) and was undeﬁned in
2/38 patients (5%).
All patients were subjected to percutaneous management of
their metal stent occlusion which was successful in the 38/39
patients (97.4%). One technical failure was in a patient with a
hilar tumor where percutaneous insertion of an external cathe-
ter was done because of inability to pass through the occluded
metal stent after 3 times of trial. The remainder of the patients
who had successful interventions were enrolled in the study. Of
them, the intervention succeeded in 18 patients out of the 38
patients (47.3%) from the ﬁrst trial, 8 patients (21%) from
the second trial and 12 patients (31.5%) from the third trial.
No major complications occurred following management
of metal stent occlusion by any method with no signiﬁcant
difference between the studied groups.Following management of the occluded stents, overall
bilirubin decreased from a median of 16.0 (7.5–34.3) to 4.1
(1.2–5.7) mg/dl (p< 0.05). There were no signiﬁcant differences
between the one-month bilirubin level after treatment (1.8 ver-
sus 2.1 versus 2.05) in the studied groups respectively
(P> 0.05). The median follow up was 75 days (range 14–353)
following insertion of group (1), 128 days (7–370) for group
(2), and 176 days (9–278) for group (3). At a mean of 6 month
follow up, 12/18 patients (66%) of group (1), 10/15 (66%) of
group (2), and 3/5 (60%) of group (3) had died.Median survival
after management of the initial metal stent occlusion was
70 days (22–118), 98 days (54–142), and 84 days (30–98) respec-
tively. There was no statistical difference in survival between the
different treatment groups. Secondary occlusion recurred in 6
patients (33%) in group (1) (who had another metal stent
inserted), in 5 patients (33%) of group 2 (replaced by another
catheters), and in 2 patients (40%) of group 3. The median bil-
iary patency following management of the primary metal stent
occlusionwas 75 days, 90 days for internal–external and 71 days
for mechanical cleaning respectively. There was no statistical
difference in biliary patency between the different treatments.
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Fig. 3 Male patient, 74 years old, HCV +ve, diagnosed with distal malignant biliary obstruction due to peri-ampullary lesion. A metal
stent was inserted. Jaundice recurred 30 days later. Picture A represents the old function stent. However, re-cholangiography revealed
upward migration of the stent (E and F), and 10 F pigtail catheter was inserted as external drain through left approach. Two days later,
10 · 94 mm uncovered wall stent was inserted (D), dilated by 8 · 40 mm balloon (E), cholangiography revealed adequate drainage (F).
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Fig. 4 58 years old, diagnosed with distal malignant biliary obstruction (advanced pancreatic head neoplasm). Cholangiography (A)
showed abrupt contrast stoppage at common hepatic duct denoted by the ﬁlling defect before stent (obstruction proximal to the stent)
with no ﬂow inside the stent. Wire and catheter could be advanced through the stent that showed damped ﬂow (tumor in-growth) (B and
C). Wallstent was deployed inside the old one and dilated (D) and re-cholangiography conﬁrmed free ﬂow (E).
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Evaluation of different percutaneous modalities 655Table 2 shows the deferential data of clinical outcomes of the
groups.
The mean number of percutaneous interventions per
patient was 1.3 in the second metal stent group (1), 2.44 in
the internal–external catheters group (2), and 2.4 in the
mechanical cleaning group (3). The incremental cost of placing
a second metal stent was triple that of the internal–external
catheter and that of the mechanical cleaning. The total cost
effectiveness ratio of a second metal stent versus plastic inter-
nal–external catheters was therefore higher. The incremental
cost of placement of a second metal stent versus mechanical
cleaning was also double of the cost. The cost effectiveness
ratio of a second metal stent versus mechanical cleaning was
also higher. The incremental cost of a plastic internal–external
catheter versus mechanical cleaning was 40%. Thus, placement
of a second metal stent is economically the most cost compared
to either plastic internal–external catheter or mechanicalA B
D E
G H
Fig. 5 53 years old, diagnosed with distal malignant biliary obstruc
ERCP due to cardiomyopathy. His CT (A–D) shows proximal extra-ste
duct. Cholangiography conﬁrmed the ﬁlling defect before stent (obstru
Dilatation was done using 8 · 40 mm balloon catheter (G), 10 F intern
bile ﬂow (H). Picture I is plain ﬁlm to conﬁrm shaping of the drain.cleaning. Placement of a plastic internal–external catheter
compared with mechanical cleaning and another metal stent
is the least.4. Discussion
Most reports of the management of occluded metal stents used
in the biliary tree have either been case reports or a small part
of a larger series evaluating other primary endpoints in the efﬁ-
cacy of metal stents (3). In addition, long term results have not
been published for placement of a second Metal stent or
mechanical cleaning. Our retrospective study is the ﬁrst to
compare the different methods of treating metal stent occlu-
sion and also has the largest number of patients with occluded
metal stents in one series. We found no signiﬁcant differences
in the duration of patency or survival after managing metalC
F
I
tion due to pancreatic head neoplasm and patient was not ﬁt for
nt tumor tissue (tumor overgrowth) occluding the common hepatic
ction proximal to the stent) with no ﬂow inside the stent (E and F).
al–external drain was inserted through the metallic stent with good
656 M. Alwarraky et al.stent occlusions by insertion of another metal stent, internal–
external catheters, or mechanical cleaning. Thus all these
methods of treatment appear to be equally effective. As med-
ian survival of patients following management of metal stent
occlusion was three months or less, the least costly method
of treatment was that of plastic internal–external catheters as
the insertion of another metal stent did not seem to have the
advantage of longer patency. This is conﬁrmed by incremental
cost effectiveness analysis. As our study was retrospective and
the subjects were not randomly allocated, ﬁrm conclusions
cannot be drawn until a prospective randomized and stratiﬁed
study in larger numbers conﬁrms our ﬁndings. However data
from such a study are unlikely to be available for some time.G
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Fig. 6 Male patient, 65 years old, with history of left metal biliary
jaundice and US (A and B) showed mild left dilated radicles, CBD dist
minimal radicles in the left lobe and no tumor overgrowth (C–F). P
papillary end was dilated (I) and 10 F pigtail catheter was inserted as in
and K.The median duration of patency of the primary metal stent
in our study was 3.5 months which is less than the 8–10 months
in previously reported studies (4).
This may be due to a selection bias in our series
which studied only patients whose metal stents became
occluded. The duration of patency of other metal stents
which did not occlude in the patients’ lifetime was not
included.
An incremental cost effectiveness analysis was performed
because the three treatments for metal stent occlusion differed
only with respect to the equipment price as all appeared to be
equally effective. Although cholangiography related costs vary
between different countries, it is apparent that the most costF
C
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stent because of hilar cholangiocarcinoma. One month later, got
ended with echogenic structure occluding the stent. His CT showed
TC (G and H) showed ﬁlling defects intrastent. The stent at the
ternal–external drain. Good duodenal ﬂow of contrast is seen in J
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Fig. 7 Male patient, 76 years old, with history of biliary stent secondary to peri-ampullary lesion. ERCP: patient not ﬁt as cardiac with
history of mitral valve replacement. Patient got jaundiced. His CT (A–D) shows biliary radicle dilatation with no tumor ingrowth. The
stent appears compressed at middle and proximal ends. Cholangiography (E–J) revealed occluded stent, with no ﬂow to duodenum.
Balloon dilatation and external drain were done through right approach using 10 F pigtail catheter with cleaning of big amount of bile
sludge and gravels (I). Two days later, cholangiography (J) revealed satisfactory drainage and collapsed radicles.
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external catheters within the metal stent.
The major cause of metal stent occlusion was tumor
ingrowth in 19 of 38 occlusions (50%), conﬁrming previous
observations (1). This problem may be overcome by the devel-
opment of a silicone covering (5); or the emergence of newer
metallic stents which do not have an open framework, butadditional problems may ensue, including stent migration
and impairment of branch duct drainage in hilar lesions as well
as potential obstruction of the pancreatic and cystic duct
oriﬁces.
The median patency of the second metal stent within a
metal stent is relatively short at only 75 days which is less than
that of the ﬁrst metal stent (102 days). The lack of prolonged
Table 2 Clinical outcome and follow up of both studied groups.
Parameter Group 1 (n= 18) Group 2 (n= 15) Group 3 (n= 5)
No % No % No %
Clinical success rate 11 61 9 60 3 60
Re-occlusion 6 33 5 33 2 40
30 day mortality 2 11 2 13 0 0
Mortality at 6 months 12 66 10 66 3 60
658 M. Alwarraky et al.patency following the second metal stent insertion is one of the
reasons why it has little advantage over insertion of plastic
internal–external catheters. This may be because the majority
of metal stent occlusions are due to tumor ingrowth, and
placement of a second metal stent within the ﬁrst metal stent
does not prevent this problem from recurring. On the other
hand, plastic internal–external catheters within a metal stent
may prevent re-occlusion due to tumor ingrowth although
the plastic internal–external catheters itself are prone to sludge
encrustation (6).
The positive correlation between the period of patency of
the ﬁrst metal stent and the period of patency following treat-
ment of the occlusion suggests that patients with early stent
occlusion will occlude early following the second procedure.
Furthermore, patients whose metal stents remain patent for
a long time may also have a longer patency following treat-
ment of the occlusion. It could be argued that patients with
early metal stent occlusion may be selected for a subsequent
cheaper procedure such as plastic internal–external catheters
while patients with longer metal stent patency might do better
with another metal stent. To determine whether such a strategy
could be cost effective would require a large prospective
randomized study.
Mechanical cleaning of the stent with dilatation appeared
valuable. Debris may be caused by the rough surface of the
stent, increased roughens by tumor in-growth and by the
mechanical compression of the tumor by time. Although there
appeared to be a trend for a lower stent patency and survival
following mechanical cleaning to treat a metal stent occlusion,
this was not statistically signiﬁcant. However the number of
patients in the group who had mechanical cleaning is small
and larger numbers may be required to conﬁrm this. Three
studies compared this procedure to a second stent insertion
as stent-in-stent after SEMS occlusion (7,8,4). Bueno et al.
Ah Bueno et al. (8) suggested that mechanical cleaning was less
effective than SEMS and PS stent insertions (median duration
of stent patency after re-intervention 21 d; range 3–263 d,
192 d; range 81–257 d, and 90 d; range 11–393 d, respectively).
A similar outcome has also been shown by Rogart et al. Ad
Rogart et al. (4) (median days to re-intervention 43 d, 172 d
and 66 d; P< 0.05 respectively). Although, Tham et al. ag
Tham et al. (7) demonstrated no signiﬁcant differences in the
durations of the biliary patency among the three methods,
there was a trend toward lower patency duration in a groupwho underwent mechanical cleaning when compared with
groups who underwent SEMS and PS insertions.
In contrast none of the patients in our study had signiﬁcant
procedure-related complications following treatment of their
occluded metal stents.
In conclusion, although all three methods are equally
effective in managing an occluded metal stent, insertion of a
plastic internal–external catheter within a metal stent
appears to be the most cost effective method; in some health
care environments, mechanical cleaning may be as cost
effective. A prospective randomized study is required to
conﬁrm this.Conﬂict of interest statement
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